1. Home
  2. Analysis
  3. Duobrii
  4. Levothyroxine-sodium

Duobrii and Levothyroxine sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Duobrii (halobetasol propionate; tazarotene) and Levothyroxine sodium (levothyroxine sodium). Common drug interactions include psoriasis among females.

The phase IV clinical study analyzes what interactions people have when they take Duobrii and Levothyroxine sodium. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Duobrii?

Duobrii has active ingredients of halobetasol propionate; tazarotene. eHealthMe is studying from 212 Duobrii users. Check the latest studies of Duobrii.

What is Levothyroxine sodium?

Levothyroxine sodium has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 129,812 Levothyroxine sodium users. Check the latest studies of Levothyroxine sodium.

On Jul, 07, 2026

11 people who take Duobrii and Levothyroxine sodium together, and have interactions are studied.

Duobrii and Levothyroxine sodium drug interactions.

What are the common drug interactions of Duobrii and Levothyroxine Sodium, by gender? *:

female:

  1. Psoriasis (immune-mediated disease that affects the skin)
  2. Abdominal pain
  3. Skin ulcer
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. White blood cell count increased
  6. Therapeutic response decreased (less preventive response)
  7. Blood glucose increased
  8. Localised infection (infection at the single location)
  9. Dysplasia (enlargement of an organ or tissue)
  10. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)

male:

n/a

What are the common drug interactions of Duobrii and Levothyroxine Sodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Psoriasis (immune-mediated disease that affects the skin)
  2. Therapeutic response decreased (less preventive response)
  3. Dizziness
  4. Dysplasia (enlargement of an organ or tissue)
  5. Headache (pain in head)
  6. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  7. Tinnitus (a ringing in the ears)

60+:

n/a

What are the existing conditions these people have? *

  1. Psoriasis (immune-mediated disease that affects the skin): 6 people, 54.55%
  2. Immunodeficiency Common Variable: 5 people, 45.45%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 27.27%

* Approximation only. Some reports may have incomplete information.

Do you take Duobrii and Levothyroxine sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Duobrii and Levothyroxine sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Duobrii:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Levothyroxine sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Duobrii and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levothyroxine sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on halobetasol propionate; tazarotene and levothyroxine sodium (the active ingredients of Duobrii and Levothyroxine sodium, respectively), and Duobrii and Levothyroxine sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.